Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. - Test2 - elhamkhani - TriplyDB

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.

http://www.wikidata.org/entity/Q44965243

about

Update on Sclerosing Cholangitis in Critically Ill Patients The genetics of complex cholestatic disorders Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging.A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography.β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.Modeling hepatic osteodystrophy in Abcb4 deficient mice ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease Bile formation and secretion.Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models.Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.Vitamin D modulates biliary fibrosis in ABCB4-deficient mice.Generation of a cholangiocyte-specific cDNA expression library for the identification of B and T cell autoantigens in murine biliary disease.Role for hedgehog pathway in regulating growth and function of invariant NKT cells.Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.Gallstone disease.Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma Current research on the treatment of primary sclerosing cholangitis.Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.Fibrosis in autoimmune and cholestatic liver disease Epidermal growth factor protects the apical junctional complexes from hydrogen peroxide in bile duct epithelium.Primary sclerosing cholangitis--the arteriosclerosis of the bile duct?Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.Characterization of animal models for primary sclerosing cholangitis (PSC).Functional and structural features of cholangiocytes in health and disease.Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat.

P2860

Q26782875-64CC2968-EDE2-46C4-A653-BD859B7D1F82 Q26992279-DD9300E7-FE2C-459F-8D7A-9E62C75B937B Q27015831-EEB5E2C7-2BAA-4DEE-99C3-6DE79F0016DC Q27322930-19B66F83-82C5-4CE9-B7E7-4EB57057E462 Q27334969-F66CC21F-FA79-4F5E-A54E-CAA53EAFE562 Q28076453-918152C9-DDB3-45E2-960B-D7E1E61B3BF5 Q28240299-F12EB48A-0829-4297-9DA9-5CB0A3754139 Q28476642-A18D78A5-C324-429E-8F9D-27CE5CFC4432 Q28568715-E17AC081-FD58-4F5C-9FA1-13201DCC566E Q30363355-B791657D-BCF7-45D0-B355-33C1C56755B0 Q30479829-BA231529-0047-42DA-A9C5-1213818D1FBC Q30535328-67FCBC4A-C288-43CF-B7B5-97E12FE61A0D Q30560951-0453137D-1002-422B-B922-5525D1D03205 Q33710554-8E0F9F56-5F23-40B5-A56C-020E6470569B Q33824596-F7E87AFF-8662-4A8C-92FE-D888BB780DA4 Q33844494-D4276DE5-755C-4C10-B38F-4750C5D4DBD3 Q33866788-91A43638-8F69-4D08-9B88-B4A95C87513D Q33881922-7AD1E0C8-5CF1-46D7-8FEA-742D097500D1 Q33920338-D2ECEB5D-E66F-473C-A6FA-869AE1A0095A Q34017604-0E887318-2D65-407C-B1C0-C9555E75E41D Q34104332-BE5C623B-F494-4067-A12C-FC0B5195741F Q34124208-6AD76BDD-834D-4733-B8D8-C33505D15918 Q34247943-191AB0D5-6B1E-43FC-864D-6FC9AAA5AEE2 Q34287861-65384A32-F574-485E-BD9A-A1D496D926C7 Q34438060-FCCB7A59-147A-4D26-8F54-EAA9381B9839 Q34479345-E62C42C3-0784-4AA4-A490-C877A6A203F2 Q34482519-F323B6EA-5886-4E7E-BD7B-80471CB13978 Q34634193-1766F4FB-8D4E-4476-A743-2F51D2D8B543 Q34854093-F40C7273-F473-4743-BF7D-2B348321844C Q34983476-59B4A2EA-B339-4363-A1B2-038202F3DEE1 Q35010217-11881D68-B1C7-4452-873F-5D42BB155857 Q35066561-84D89667-A720-4B22-A30D-55D0A40D278F Q35087943-F612B494-A351-420F-85D4-DE6CA7326BDB Q35098677-229AC0C5-9223-4945-B57E-012964C0CDA5 Q35182081-D4F8CE25-E8FE-4C70-AE8A-AA62451EEEF6 Q35632527-1F634F8B-E4AD-44C3-BA99-5B8A1D047309 Q35793705-CC337CB4-E2C8-4DDD-B961-7563F155C2B1 Q35896870-9ED40F8F-BFC8-4113-8F33-9110BEDB2803 Q35933236-C9D9249E-55A6-4A3E-9F1B-5B442D8BBB42 Q36114945-64DA5AD3-0911-4509-A307-0E81E6376AFC

P2860

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.

http://www.wikidata.org/entity/Q44965243

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Regurgitation of bile acids fr ...... in Mdr2 (Abcb4) knockout mice.

@en

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2

@nl

type

label

Regurgitation of bile acids fr ...... in Mdr2 (Abcb4) knockout mice.

@en

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2

@nl

prefLabel

Regurgitation of bile acids fr ...... in Mdr2 (Abcb4) knockout mice.

@en

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2

@nl

P1433

Q44965243-4E50B695-AA89-470C-8427-024437B7A31C

P1476

Q44965243-6F96D475-EC31-42B0-AFD6-23C7488CC46E

P2093

Q44965243-11746694-E1FD-4A87-84BD-1311D36272C4

Q44965243-1EB083B3-ACCC-48E2-B742-5C167A8682DA

Q44965243-521CD3A7-CA8D-4E74-AA85-003E0A5CBC0F

Q44965243-56BF197C-D191-4C58-A59D-0E892F89B065

Q44965243-5E698ED4-D21A-4CB8-B8E1-7E79EF050307

Q44965243-89E6BDAB-FE92-4BDA-8192-B6E51BB02600

Q44965243-932AABA2-5A7E-4D2A-980A-1A9E9EA186DB

Q44965243-94B087DB-C54A-45F6-A361-3D4AA928FFB8

Q44965243-AF17C248-689A-4FE4-A498-FF2CBF56F246

Q44965243-B89AA83C-CE3C-4578-A451-4E411A1B8695

P304

Q44965243-464265C5-C93A-4F1B-A616-E1335D601C99

P31

Q44965243-7CEF31A3-6F7C-444C-BAC9-284196CD4DAF

P356

Q44965243-07DA792D-B646-49BA-AD1C-02DDC975BE88

P407

Q44965243-4B3C2AE4-F81E-4B29-971C-915D0F2B7DC1

P433

Q44965243-61C244D1-D2A6-44D7-ADA3-90D0311889FB

P478

Q44965243-884D5A48-577A-4668-A888-7AE298D114E7

P50

Q44965243-1016BDD0-E876-415C-8A03-178A479861DF

Q44965243-D9F0A3B5-680A-4EB4-8190-6FF7D8DC0B64

P577

Q44965243-30827092-53DA-4F68-A837-854E482EA864

P5875

Q44965243-D85E80E5-57E5-4416-A4B9-7D967787B77A

P698

Q44965243-237E8A4D-5D26-4CCC-84C1-5FEECF7D4901

P921

Q44965243-6BC74835-8F84-490D-8DCD-D775C3096D89

Q44965243-A783EEDE-7D52-45ED-8B1C-DC1ED0F01836

P356

J.GASTRO.2004.04.009

P1433

Gastroenterology

P1476

Regurgitation of bile acids fr ...... in Mdr2 (Abcb4) knockout mice.

@en

P2093

Andrea Fuchsbichler

http://www.w3.org/2001/XMLSchema#string

Arthur Kaser

http://www.w3.org/2001/XMLSchema#string

Cord Langner

http://www.w3.org/2001/XMLSchema#string

Frank Lammert

http://www.w3.org/2001/XMLSchema#string

Hanns-Ulrich Marschall

http://www.w3.org/2001/XMLSchema#string

Helmut Denk

http://www.w3.org/2001/XMLSchema#string

Herbert Tilg

http://www.w3.org/2001/XMLSchema#string

Martin Wagner

http://www.w3.org/2001/XMLSchema#string

Michael Trauner

http://www.w3.org/2001/XMLSchema#string

Peter Fickert

http://www.w3.org/2001/XMLSchema#string

P304

261-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2004.04.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8473123

http://www.w3.org/2001/XMLSchema#string

P698

15236191

http://www.w3.org/2001/XMLSchema#string

P921